PharmaShots | Incisive News in 3 Shots

Subscribe Now

Self-Administered Therapy

Novartis' Kesimpta (ofatumumab) Receives the US FDA's Approval as the First Self-Administered Therapy for Relapsing Multiple Sclerosis

Novartis' Kesimpta (ofatumumab) Receives the US FDA's Approval as the First Self-Administered Therapy for Relapsing Multiple Scler...

August 21, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us